GTC Biotherapeutics (fka GTCB)

[Spice is nice]

That is one way to look at it.

Another way is this is one more collaboration supporting an admission by GTC that it cares far more about their baby than their corporate health.

http://biz.yahoo.com/bw/070302/20070302005629.html?.v=1

I see no terms there. No terms mean no revenues of substance. No revenues of substance means the IP is being diluted almost as fast as the stock.

Another poster of this board revealed how GTC actually loses money providing a similar service for Merrimack, so the question "can GTC and its shareholders actually afford these developmental contracts" is a considerable one.